Adalimumab desensitization after anaphylactic reaction

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 6, 2011, Pages 547-548

  Quercia, Oliviero ^a   Emiliani, Francesca ^a   Foschi, Francesco Giuseppe ^a   Stefanini, Giuseppe Francesco ^a  

^a Ospedale per gli Infermi di Faenza   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIHISTAMINIC AGENT; CORTICOSTEROID; ETANERCEPT; LEFLUNOMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; CASE REPORT; DESENSITIZATION; DISEASE EXACERBATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FACIAL ANGIOEDEMA; FEMALE; HUMAN; HYPOTENSION; LETTER; PRICK TEST; PRIORITY JOURNAL; PRURITUS; RHEUMATOID ARTHRITIS; TREATMENT DURATION; URTICARIA;

ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MIDDLE AGED; SKIN TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957923560     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2011.03.014     Document Type: Letter

References (7)

1. Burmester GR, Mease P, Dijkmans BAC, et al. Adalimumab safety and mortality rates from global clinical trials of six immune mediated inflammatory diseases. Ann Rheum Dis. 2009;68:1863-1869.
2. Lovell DJ, Ruperto N, Goodman S, et al Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008;359:810-820.
3. Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis-2: the era of biologicals. Arch Dis Child Pract Ed. 2009;94:151-156.
4. Campi P, Benucci M, Manfredi M, Demoly P. Hypersensitivity reaction to biological agents with special emphasis on tumor necrosis factor-alpha antagonist. Curr Opin Allergy Clin Immunol. 2007;7:393-403. (Pubitemid 47415282)
5. Brennan PJ, Rodriguez Bouza T, Hsu FI., Sloane DE, Castells MC. Hypersensitivity reaction to mAb: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol. 2009;124:1259-1266.
6. Breslow RG, Caiado J, Castells MC. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Ann Allergy Asthma Immunol. 2009;102:155-160.
7. Rodriguez-Jiménez B, Domínguez-Ortega J, González-Herrada C, Kindelan- Recarte C, Loribo-Bueno P, Garrido-Peño N. Successful adalimumab desensitization after generalized urticaria and rhinitis. J Invest Allergol Clin Immunol. 2009;19:237-252.